MedTrace Logo

A Cohort for Evaluation of Open-label PrEP Use and PreP Preferences Among African Women

NCT05746065 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3087

Last updated 2024-05-08

No results posted yet for this study

Summary

INSIGHT is a Prospective, Observational, open-label cohort study on women in Sub-Saharan Africa on PrEP screening, informed choice, and compliance.

There are no specific intervention arms or comparative treatment plans. We will follow and observe participants taking PrEP, not taking PrEP, as well as those who begin or end PrEP during the course of the observational period.

Conditions

  • HIV Infections

Interventions

DRUG

PrEP

Eligible women will be prescribed PrEP intake in accordance to standard of care should they choose. We are interested in observing adherence, barriers to adherence, and other factors that effect sexual health.

Sponsors & Collaborators

Principal Investigators

  • Connie Celum, MD · University of Washington

Eligibility

Min Age
16 Years
Max Age
31 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2023-08-01
Completion
2023-08-01

Countries

  • Eswatini
  • Kenya
  • Malawi
  • South Africa
  • Uganda
  • Zambia
  • Zimbabwe

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05746065 on ClinicalTrials.gov